Erika Michelle Benabe-Gonzalez M D is categorized under Family Practice Doctors in , and active since 2011.
Erika Michelle Benabe-Gonzalez M D was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact E Michelle Benabe-Gonzalez at the company’s single location by writing to 400 Calle M Domenech # 307, , 00918 or by phoning (787) 379-4777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Erika Michelle Benabe-Gonzalez M D |
Contact Person: | E Michelle Benabe-Gonzalez |
Address: | 400 Calle M Domenech # 307, , 00918 |
Phone Number: | (787) 379-4777 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Erika Michelle Benabe-Gonzalez M D was started in 2011 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact E Michelle Benabe-Gonzalez for inquiries that concern Erika Michelle Benabe-Gonzalez M D by calling the company number (787) 379-4777, as your correspondence is most welcome. Additionally, the physical location of the single location of Erika Michelle Benabe-Gonzalez M D can be found at the coordinates 18.412699,-66.06939 as well as the street address 400 Calle M Domenech # 307 in , 00918.
For its online presence, you may visit Erika Michelle Benabe-Gonzalez M D’s website at and engage with its social media outlets through on Twitter and on Facebook.